Contact
Please use this form to send email to PR contact of this press release:
KYTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
TO: